Neomycin is a member of the aminoglycosides, aminoglycosidic aminocyclitols consisting of a six-membered aminocyclitol ring attached to aminosugar side chains through a glycosidic bond. Technical Advantage: Effective against Gram-positive and -negative bacteria Neomycin, a nucleoside antibiotic and aminoglycoside, is a protein synthesis inhibitor that causes premature chain termination by acting as an analog of the 3'-terminal end of aminoacyl-tRNA. It prevents growth of bacteria, protozoa, algae, and mammalian cells. Organisms carrying the resistance gene puromycin acetyltransferase are effectively protected from this compound. Neomycin is effective against Gram-negative and Gram-positive bacteria.
Complete Certificate of Analysis available for each production lot, along with full formulation information Manufactured in a facility that complies with ISO 13485 certified quality system. This product is produced under high quality industry standards.